# Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer

> **NCT01717482** · PHASE2 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 6 (actual)

## Conditions studied

- Lung Neoplasms
- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** Metformin
- **OTHER:** Placebo Comparator

## Key facts

- **NCT ID:** NCT01717482
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10
- **Primary completion:** 2019-05-22
- **Final completion:** 2019-05-22
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Poor accrual and funding ended
- **Last updated:** 2020-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01717482

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01717482, "Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01717482. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*